基于NKG2D的癌症免疫治疗药物的设计
Jianfeng Han1, Youwei Wang2, Godfrey Chi-Fung Chan3,4
1Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, United States.
Frontiers in immunology
|July 4, 2025
概括
基于自然杀手组2D (NKG2D) 受体的疗法在癌症治疗方面表现有前途. 本综述将NKG2D CAR和抗体设计进行比较,评估它们对固体瘤的临床前和临床有效性.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 自然杀手组2D (NKG2D) 是NK细胞上的激活受体,对癌症免疫监测至关重要.
- NKG2D 配体在各种癌细胞上升调节,使得 NKG2D 成为癌症免疫治疗的目标.
- 人类和小鼠NKG2D受体表现出不同的信号通路 (DAP10与DAP10/12),影响效应器功能.
研究的目的:
- 审查和比较基于NKG2D的仿真抗原受体 (CAR) 和抗体的各种设计.
- 分析基于NKG2D的不同免疫治疗策略的优缺点.
- 总结这些基于NKG2D的疗法在固体瘤中的临床前和临床研究.
主要方法:
- 关于基于NKG2D的CAR和抗体的已发表研究的文献综述.
- 对不同CAR和抗体设计及其组件 (例如,细胞外,全长域) 的比较分析.
- 对基于NKG2D的治疗方法的临床前癌症模型和临床试验数据的检查.
主要成果:
- 使用各种NKG2D领域开发了NKG2DCAR和抗体.
- 临床前研究主要集中在固体瘤上,T细胞和NK细胞作为效应平台.
- 人类和小鼠NKG2D信号影响因子功能的差异,如IFN-γ的产生和细胞毒性.
结论:
- 基于NKG2D的CAR和抗体代表了癌症免疫治疗研究的一个有前途的领域.
- 了解不同的信号通路对于优化治疗策略至关重要.
- 需要在临床前和临床环境中进行进一步的研究,以评估基于NKG2D的治疗的全部潜力.
更多相关视频
相关概念视频
Tumor Immunotherapy
665
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
665
Cancer Vaccines
517
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
517
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cytotoxic T Cells-mediated Immune Response
2.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.4K


